| 产品名称： | Rotavirus reassortant |
|---|---|
| 商品货号： | TS192516 |
| Classification： | Reoviridae, Rotavirus |
| Agent： | Rotavirus reassortant |
| Strain： | HCR3a |
| Applications： | vaccine production |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | stool from a human infant 3 days after oral administration of bovine rotavirus vaccine WC3 |
| Product Format： | frozen |
| Storage Conditions： | -70°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | may cause gastroenteritis in infants -70C Propagate in cell culture with serum-free media with 0.5 ug/ml trypsin. serotype 3, subgroup 1 |
| Effect on Host： | Yes, in vitro effects: vague CPE (rounding and cell detachment) Vague CPE; rounding and cell detachment |
| Recommended Host： | MA-104 cells (ATCC CRL-2378) Host of Choice:xa0 MA-104 (CRL-2378) Host Range: MA-104, CV-1, Vero MA-104 cells (ATCC CRL-2378); CV-1 cells (ATCC CCL-70); Vero cells (ATCC CCL-81) |
| Growth Conditions： | Duration: 3-8 days at 37C |
| Cryopreservation： | Storage temperature: -70C |
| Name of Depositor： | Wistar Institute of Anatomy and Biology |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Source： | stool from a human infant 3 days after oral administration of bovine rotavirus vaccine WC3 |
| References： | Clark HF. Human rotavirus HCR3a and method of growing said rotavirus. US Patent 5,610,049 dated Mar 11 1997 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Rotavirus reassortant |
|---|---|
| 商品货号： | TS192516 |
| Classification： | Reoviridae, Rotavirus |
| Agent： | Rotavirus reassortant |
| Strain： | HCR3a |
| Applications： | vaccine production |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | stool from a human infant 3 days after oral administration of bovine rotavirus vaccine WC3 |
| Product Format： | frozen |
| Storage Conditions： | -70°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | may cause gastroenteritis in infants -70C Propagate in cell culture with serum-free media with 0.5 ug/ml trypsin. serotype 3, subgroup 1 |
| Effect on Host： | Yes, in vitro effects: vague CPE (rounding and cell detachment) Vague CPE; rounding and cell detachment |
| Recommended Host： | MA-104 cells (ATCC CRL-2378) Host of Choice:xa0 MA-104 (CRL-2378) Host Range: MA-104, CV-1, Vero MA-104 cells (ATCC CRL-2378); CV-1 cells (ATCC CCL-70); Vero cells (ATCC CCL-81) |
| Growth Conditions： | Duration: 3-8 days at 37C |
| Cryopreservation： | Storage temperature: -70C |
| Name of Depositor： | Wistar Institute of Anatomy and Biology |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Source： | stool from a human infant 3 days after oral administration of bovine rotavirus vaccine WC3 |
| References： | Clark HF. Human rotavirus HCR3a and method of growing said rotavirus. US Patent 5,610,049 dated Mar 11 1997 |
